CAS 1801333-55-0

PF-06952229

CAS: 1801333-55-0

PF-06952229

Purity: ≥98%

Molecular weight: 458.91g/mol

Ref: 54-BUP04138

PF-06952229

CAS: 1801333-55-0

PF-06952229 is an inhibitor analog that targets kinase enzymes. It has been shown to be effective in reducing the activity of certain kinases found in human urine and cancer cells, making it a promising candidate for anticancer therapy. This inhibitor selectively induces apoptosis, or programmed cell death, in tumor cells by inhibiting specific protein kinases that are involved in cancer cell growth and proliferation. PF-06952229 has also demonstrated efficacy against oseltamivir-resistant influenza viruses. This compound is highly selective and does not affect other kinases or proteins, making it a safe and effective treatment option for various types of cancer.

Formula: C₂₃H₂₄ClFN₄O₃

Purity: Min. 95%

Molecular weight: 458.9 g/mol

Ref: 3D-BXC33355